{ "items": [ "\n\n
\n \n Journal article\n \n
\n \n\n \n \n \nDi Simplicio M. et al, (2016), JOURNAL OF PSYCHOPHARMACOLOGY, 30
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPetersen I. et al, (2016), Schizophr Res, 176, 349 - 356
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSharpley AL. et al, (2016), Psychopharmacology (Berl), 233, 3429 - 3435
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nNgamchuea K. et al, (2016), Analyst, 141, 4707 - 4712
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nSammon CJ. et al, (2016), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25, 237 - 238
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCowen P., (2016), Lancet Psychiatry, 3, 592 - 593
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMasaki C. et al, (2016), Psychopharmacology (Berl), 233, 2655 - 2661
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPringle A. et al, (2016), Psychopharmacology (Berl), 233, 2221 - 2228
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSingh N. et al, (2016), Neuropsychopharmacology, 41, 1768 - 1778
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nMasaki C. et al, (2016), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 19, 65 - 66
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSchmaal L. et al, (2016), Mol Psychiatry, 21, 806 - 812
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nIronside M. et al, (2016), Biol Psychiatry, 79, 823 - 830
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMasaki C. et al, (2016), Psychopharmacology (Berl), 233, 1097 - 1104
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nMasaki C. et al, (2016), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 26, S66 - S67
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPetersen I. et al, (2016), Health Technol Assess, 20, 1 - 176
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMaron E. et al, (2016), J Psychopharmacol, 30, 33 - 39
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSelvaraj S. et al, (2015), Biol Psychiatry, 78, 563 - 571
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPringle A. et al, (2015), J Psychopharmacol, 29, 1129 - 1132
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nMcCrea RL. et al, (2015), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 24, 23 - 24
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nPetersen I. et al, (2015), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 24, 260 - 260
\n \n \n \n\n \n
\n \n \n